Related Experiment Video

Updated: May 26, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Relation between serum bilirubin levels ≥450 μmol/L and bilirubin encephalopathy; a Danish population-based study

Finn Ebbesen1, Jesper V Bjerre, Pernille K Vandborg

  • 1Department of Paediatrics, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark. fe@rn.dk

Acta Paediatrica (Oslo, Norway : 1992)
|December 20, 2011
PubMed

Insights

Infants with total serum bilirubin (TsB) levels of 600 μmol/L or higher face a significant risk of developing severe bilirubin encephalopathy. This study highlights the importance of monitoring TsB in newborns to prevent long-term neurological damage.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Public Health

Background:

  • Hyperbilirubinemia is a common condition in newborns.
  • Severe hyperbilirubinemia can lead to bilirubin encephalopathy, a serious neurological condition.
  • Understanding the relationship between bilirubin levels and encephalopathy is crucial for timely intervention.

Purpose of the Study:

  • To investigate the association between high total serum bilirubin (TsB) levels (≥450 μmol/L) and the incidence of acute intermediate, acute advanced, and chronic bilirubin encephalopathy in infants.
  • To quantify the risk and incidence of bilirubin encephalopathy in infants with TsB ≥450 μmol/L.

Main Methods:

  • A population-based cohort study was conducted using data from Denmark between 2000 and 2007.
  • Identified infants born at ≥35 weeks gestational age with TsB ≥450 μmol/L from a national laboratory information system.
  • Bilirubin encephalopathy diagnoses were obtained from the Danish National Registry of Patients.

Main Results:

  • The incidence of TsB ≥450 μmol/L was 45 per 100,000 infants per year, showing an increasing trend.
  • Three infants with TsB ≥544 μmol/L developed acute advanced bilirubin encephalopathy with severe sequelae.
  • Infants with TsB levels of 600-1000 μmol/L had a 27% risk of acute advanced and chronic bilirubin encephalopathy, with an incidence of 0.6 per 100,000.

Conclusions:

  • The incidence of severe hyperbilirubinemia (TsB ≥450 μmol/L) in newborns is significant.
  • A TsB level of 600 μmol/L or higher is associated with a substantial risk of acute advanced and chronic bilirubin encephalopathy.
  • Close monitoring and management of hyperbilirubinemia in infants are essential to prevent severe neurological outcomes.
Abstract

More Related Videos

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke12:19

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke

Published on: March 11, 2018

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...